22nd Century Group Stock Set to Reverse Split on Tuesday, April 2nd (NASDAQ:XXII)

22nd Century Group, Inc. (NASDAQ:XXII)’s stock is scheduled to reverse split on Tuesday, April 2nd. The 1-16 reverse split was announced on Tuesday, April 2nd. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, April 2nd.

22nd Century Group Stock Down 8.7 %

NASDAQ XXII traded down $0.01 during trading hours on Friday, reaching $0.12. 3,495,353 shares of the company traded hands, compared to its average volume of 1,216,440. 22nd Century Group has a 12 month low of $0.10 and a 12 month high of $12.00. The company has a current ratio of 1.02, a quick ratio of 0.62 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $3.71 million, a PE ratio of -0.01 and a beta of 1.54. The company has a 50 day moving average of $0.15 and a two-hundred day moving average of $0.36.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Advisor Group Holdings Inc. raised its holdings in shares of 22nd Century Group by 35.4% during the first quarter. Advisor Group Holdings Inc. now owns 133,799 shares of the biotechnology company’s stock worth $313,000 after purchasing an additional 35,006 shares during the period. Raymond James Financial Services Advisors Inc. raised its holdings in shares of 22nd Century Group by 7.1% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 201,653 shares of the biotechnology company’s stock worth $468,000 after purchasing an additional 13,360 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of 22nd Century Group by 1.9% during the first quarter. Bank of New York Mellon Corp now owns 548,920 shares of the biotechnology company’s stock worth $1,274,000 after purchasing an additional 10,210 shares during the period. Rhumbline Advisers raised its holdings in shares of 22nd Century Group by 36.2% during the first quarter. Rhumbline Advisers now owns 155,356 shares of the biotechnology company’s stock worth $360,000 after purchasing an additional 41,293 shares during the period. Finally, Dakota Wealth Management acquired a new stake in shares of 22nd Century Group during the first quarter worth $70,000. 18.06% of the stock is currently owned by institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.